| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lineage Cell Therapeutics, Inc. (LCTX) has 8 insiders with recent SEC Form 4 filings, including 11 buys and 6 sells. LCTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $328.3K | - | |
| 10% | 75.0K | $96.4K | - | |
| Dir | 75.0K | $96.4K | - | |
| Dir | 75.0K | $96.4K | - | |
| Dir | 75.0K | $96.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | Jayasuriya Anula | Director | Buy | 10,000 | $1.09 | $10,900.00 | New | +35.8% | -54.4% | |
| Mar 31, 2022 | Culley Brian M56 | President And CEO | Buy | 6,400 | $1.53 | $9,792.00 | +7.0% | +4.5% | -2.6% | |
| Mar 28, 2022 | Amin Dipti | Director | Buy | 35,000 | $1.63 | $57,050.00 | New | 0.0% | -7.4% | |
| Mar 25, 2022 | Culley Brian M56 | President And CEO | Buy | 5,250 | $1.38 | $7,245.00 | +6.9% | -8.8% | -1.4% | |
| Mar 25, 2022 | Broadwood Partners, L.P.60 | Director, 10% Owner | Buy | 930,106 | $1.42 | $1,317,666.80 | +0.5% | -8.8% | -1.4% | |
| Mar 24, 2022 | Mulroy Michael H. | Director | Buy | 7,000 | $1.40 | $9,800.00 | +2.8% | 0.0% | +1.4% | |
| Dec 29, 2021 | Hogge Gary S. | SVP,Clinical &Medical Affairs | Sale+OE | 539,283 | $2.45 | $1,321,328.90 | -90.5% | -37.9% | -49.0% | |
| Jun 29, 2021 | Andrews Deborah J | - | Sale+OE | 19,142 | $2.93 | $56,086.06 | -55.1% | -8.9% | -45.1% | |
| Jun 29, 2021 | Russell Angus C. | - | Sale+OE | 4,720 | $2.97 | $14,018.40 | -5.1% | -8.9% | -45.1% | |
| Jun 28, 2021 | Culley Brian M56 | President And CEO | Sale+OE | 450,000 | $2.87 | $1,291,500.00 | -90.8% | -7.6% | -50.5% |